Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01078337 · ClinicalTrials.gov registry record
T-cell Minimal Residual Disease (MRD) Evaluation Using Flow Cytometric Analysis
A clinical trial of Leukemia, Lymphocytic, Acute, sponsored by Stanford University.
- Completed
- Registry status
- 15
- Enrollment target
- 1
- Study location
NCT01078337: Completed study of Leukemia, Lymphocytic, Acute, sponsored by Stanford University.
NCT01078337 is a study of Leukemia, Lymphocytic, Acute that has completed, run by Stanford University. The registered enrollment target is 15 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01078337, a study of Leukemia, Lymphocytic, Acute, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- 15 participants
- Enrollment target
- 1
- Study location
Study Summary
To determine if MRD (minimal residual disease) can be found in the blood (only) as opposed to bone marrow in children with ALL (acute lymphoblastic leukemia).
Conditions Studied
Interventions
- PROCEDURE bone marrow aspiration
- PROCEDURE peripheral blood sampling
Study Locations (1)
California
- Stanford University School of Medicine - Stanford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2002-11 |
| Est. Completion | 2007-10 |
What the finished NCT01078337 record still lists
NCT01078337 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 15 participants, a relatively small participant target.
The record links to 1 condition, with Leukemia, Lymphocytic, Acute appearing as the primary indexed condition, and to 2 interventions - of which bone marrow aspiration is the first listed.
NCT01078337 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT01078337 about?
NCT01078337 is a clinical study titled "T-cell Minimal Residual Disease (MRD) Evaluation Using Flow Cytometric Analysis". To determine if MRD (minimal residual disease) can be found in the blood (only) as opposed to bone marrow in children with ALL (acute lymphoblastic leukemia).
What is the current status of trial NCT01078337?
This trial is currently completed. The enrollment target is 15 participants. The study started on 2002-11. Estimated completion is 2007-10.
What conditions does trial NCT01078337 study?
This clinical trial studies the following conditions: Leukemia, Lymphocytic, Acute.
What interventions are being tested in trial NCT01078337?
The interventions under investigation include: bone marrow aspiration (PROCEDURE), peripheral blood sampling (PROCEDURE).
Who is sponsoring clinical trial NCT01078337?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01078337 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Leukemia, Lymphocytic, Acute
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia